[Adjuvant endocrine therapy in postmenopausal hormone-sensitive breast cancer: to start, to switch or to extend?]. [electronic resource]
Producer: 20081030Description: 133-43 p. digitalISSN:- 0025-0244
- Aged
- Anastrozole
- Androstadienes -- administration & dosage
- Antineoplastic Agents, Hormonal -- therapeutic use
- Aromatase Inhibitors -- administration & dosage
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Estrogen Receptor Modulators -- administration & dosage
- Female
- Humans
- Letrozole
- Lymphatic Metastasis -- prevention & control
- Middle Aged
- Neoadjuvant Therapy -- methods
- Neoplasm Recurrence, Local -- prevention & control
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- administration & dosage
- Postmenopause
- Quality of Life
- Randomized Controlled Trials as Topic
- Selective Estrogen Receptor Modulators -- administration & dosage
- Tamoxifen -- administration & dosage
- Treatment Outcome
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.